<html>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <meta charset="utf-8"/>
    <title>Expert Committee On Covid-19 Vaccination Updates Recommendations On Covid-19 Booster Vaccination</title>
    <body><h1>Expert Committee On Covid-19 Vaccination Updates Recommendations On Covid-19 Booster Vaccination</h1>
    <p>Published Date: 09 Feb 2023</p> <p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">1.&nbsp; &nbsp; &nbsp;</span><span style="font-size: 12pt;">For 2023, the Expert Committee on COVID-19 Vaccination (EC19V) is recommending that the following groups receive one booster dose of COVID-19 vaccine at one year after their last booster dose:</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">&nbsp;</span></span></p><p style="margin: 0cm 0cm 0cm 40px; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">(a) ages 60 years and above,</span></span></p><p style="margin: 0cm 0cm 0cm 40px; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">(b) medically vulnerable persons, or,<br></span></span><span style="font-size: 12pt; font-family: Arial;">(c) residents living in aged care facilities.</span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">&nbsp;</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">Other persons aged 12 years and above may also do so if they choose.</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><strong><span style="font-size: 12pt;">&nbsp;</span></strong></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><strong><span style="font-size: 12pt;">Additional Booster Dose Enhances Protection, Especially in Higher Risk Individuals</span></strong></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><strong><span style="font-size: 12pt;">&nbsp;</span></strong></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">2.&nbsp; &nbsp; &nbsp;</span><span style="font-size: 12pt;">The EC19V has reviewed the approach for vaccination, as the COVID-19 situation in Singapore reaches a more stable state. Periodic COVID-19 vaccination such as annual doses may be needed.</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">&nbsp;</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">3.&nbsp; &nbsp; &nbsp;</span><span style="font-size: 12pt;">Based on the current local and international epidemiological trends, as well as our updated understanding of COVID-19, the EC19V is updating its COVID-19 vaccination recommendations for the calendar year 2023.</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><strong><span style="font-size: 12pt;">&nbsp;</span></strong></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">4.&nbsp; &nbsp; &nbsp;</span><span style="font-size: 12pt;">There is currently a high level of hybrid immunity in our population, resulting from high vaccination coverage as well as a large proportion of our population having recovered from COVID-19 infection. &nbsp;Hence, protection against severe disease in boosted individuals is likely to be at a high level.</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">&nbsp;</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 16px;">5.&nbsp; &nbsp; &nbsp;Nevertheless, new variants of COVID-19 are continuing to emerge. The current protection against infection by COVID-19 will wane over time. Therefore ensuring protection against COVID-19 through vaccine booster doses remains important, especially for the groups at highest risk for COVID-19 complications.</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">&nbsp;</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">6.&nbsp; &nbsp; &nbsp;Individuals in older age groups, and patients who are immunocompromised and/or with chronic diseases (see <u><a href="/docs/librariesprovider5/default-document-library/annex9118b57b0df0497dab7b2a9cc80031ba.pdf?sfvrsn=b6e8fcbc_0" title="Annex">Annex</a></u>) are particularly vulnerable to any changes in the COVID-19 situation given their underlying susceptibility to develop severe disease, as well as COVID-19 destabilising their other medical conditions.&nbsp; Hence enhancing protection for these groups is recommended.</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">&nbsp;</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">7.&nbsp; &nbsp; &nbsp;</span><span style="font-size: 12pt;">Studies have shown that a booster dose, especially with updated bivalent vaccines, enhances protection against Omicron variants. The safety profile of additional booster doses, as well as the updated bivalent vaccines, is comparable to that of previous doses.</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">&nbsp;</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">8.&nbsp; &nbsp; &nbsp;</span><span style="font-size: 12pt;">Since persons at higher risk for severe COVID-19 will derive the greatest benefit from an additional booster dose, these groups are recommended to receive a dose in 2023 around 12 months after their last dose. Younger healthy persons may receive an additional booster around 12 months after their last dose, if they would like to do so.<br></span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><strong><span style="font-size: 12pt;"><br>Higher Risk Individuals Recommended an Additional Booster Dose in 2023</span></strong></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><strong><span style="font-size: 12pt;">&nbsp;</span></strong></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">9.&nbsp; &nbsp; &nbsp;</span><span style="font-size: 12pt;">Based on the considerations outlined above, EC19V recommends that the following persons receive in 2023, one booster dose of COVID-19 vaccine at<span> an interval of one year after their last booster dose:</span></span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">&nbsp;</span></span></p><p style="margin: 0cm 0cm 0cm 39pt; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">a.<span style="font-size: 7pt; font-stretch: normal; line-height: normal;">&nbsp;&nbsp;&nbsp; </span></span><span style="font-size: 12pt;">ages 60 years and above,</span></span></p><p style="margin: 0cm 0cm 0cm 39pt; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">b.<span style="font-size: 7pt; font-stretch: normal; line-height: normal;">&nbsp;&nbsp;&nbsp; </span></span><span style="font-size: 12pt;">medically vulnerable persons (see <u><a href="/docs/librariesprovider5/default-document-library/annex9118b57b0df0497dab7b2a9cc80031ba.pdf?sfvrsn=b6e8fcbc_0" title="Annex">Annex</a></u>), or,</span></span></p><p style="margin: 0cm 0cm 0cm 39pt; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">c.<span style="font-size: 7pt; font-stretch: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-size: 12pt;">residents living in aged care facilities.</span></span></p><p style="margin: 0cm 0cm 0cm 39pt; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">&nbsp;</span></span></p><p style="margin: 0cm 0cm 0cm 3pt; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">The updated bivalent vaccines are recommended for this. Other </span><span style="font-size: 12pt;">persons 12 years and above may also receive one booster dose at the same interval, if they choose to.</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">&nbsp;</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">10.&nbsp; &nbsp; &nbsp;</span><span style="font-size: 12pt;">Persons aged 5 years and above continue to be recommended to achieve at least <em>Minimum Protection</em> (such as three doses of the mRNA vaccines) and should proceed to get vaccinated as soon as possible, if they have not done so.</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">&nbsp;</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">11.&nbsp; &nbsp; &nbsp;</span><span style="font-size: 12pt;">Children aged 6 months to 4 years also continue to be recommended to complete their primary vaccination series by completing two doses of Moderna/SpikeVax or three doses of Pfizer-BioNTech/Comirnaty at an interval of eight weeks apart.</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">&nbsp;</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><strong><span style="font-size: 12pt;">Conclusion</span></strong></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><strong><span style="font-size: 12pt;">&nbsp;</span></strong></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">12.&nbsp; &nbsp; &nbsp;</span><span style="font-size: 12pt;">The updated recommendations take into consideration the current COVID-19 situation and the level of protection in our population. If or when a new COVID-19 variant emerges, and is assessed to pose a significant threat, there may be a need for the population at large to receive boosters at that time to ensure better protection. EC19V will provide recommendations for such a response, if required.</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">&nbsp;</span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify; line-height: normal;"><span style="font-family: Arial;"><span style="font-size: 12pt;">13.&nbsp; &nbsp; &nbsp;</span><span style="font-size: 12pt;">The EC19V continues to keep track of further developments on COVID-19 vaccines and the evolving global and local pandemic situation, and may update<span> its recommendations periodically as needed.</span></span></span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; line-height: normal;"><span style="font-size: 12pt; font-family: Arial;">&nbsp;</span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; line-height: normal;"><span style="font-size: 12pt; font-family: Arial, sans-serif;">&nbsp;</span></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; line-height: normal;"><strong><span style="font-size: 12pt; font-family: Arial;">EXPERT COMMITTEE ON COVID-19 VACCINATION</span></strong></p><p style="margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif; line-height: normal;"><strong><span style="font-size: 12pt; font-family: Arial;">9 February 2023</span></strong></p></body>
</html>